International Women’s Day 2023
Tips on career advancement, from some of LifeArc’s incredible women
Twitter outputted an error:
Invalid or expired token..
Invalid or expired token..
Honouring the contribution of a remarkable trustee – Aisling Burnand CBE
Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.
Rare Disease Day 2023 – Robbie’s story
Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.
Four ways we support rare disease research
LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.
LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient
Pump-prime funding to help researchers get innovative approaches off the ground
Celebrating the International Day of Women and Girls in Science
LifeArc celebrates this year's UN Day for Women and Girls in STEM.
Alzheimer’s drug lecanemab approved by US regulator
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
MND Collaborative Partnership cautiously welcomes new Government funding
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.